By Sneha S K and Sahil Pandey April 15 (Reuters) - Cosmo Pharmaceuticals said on Wednesday its experimental hair loss treatment showed sustained hair growth and long-term safety in men with common ...

Cosmo Pharmaceuticals has revealed topline results from two phase 3 trials which indicate that its topical cream clascoterone could become a game-changing treatment for male-pattern hair loss. The ...

Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) announced that its shareholders approved all voting items at today’s Ordinary Annual General Meeting (AGM). A total of 10,354,065 ordinary ...

Yup, we wanna hear from YOU.

Cosmo Summer Party has been making waves since 2018, hopping from one beach hotspot to another—from La Union to unforgettable ...